This brings the total funds raised so far to $25 million, the metabolic fitness platform said in a statement. Healthtech wearable glucose tracker Ultrahuman announced on Tuesday that it has raised $17.5 million in Series B funding. This brings the total funds raised so far to $25 million, the metabolic fitness platform said in a statement. Also Read | Smartwatch data can be used to predict underlying illness, study saysThe funds raised will be used for geographical expansion and to improve the company's biomarker technology. Also Read | IIT Kanpur develops touch-sensitive watch for the visually impairedThe Ultrahuman Cyborg wearable helps people optimise their exercise and nutrition based on glucose biomarkers, the statement added.

Source: The Hindu August 17, 2021 04:30 UTC